122 related articles for article (PubMed ID: 2840219)
1. The work of the WHO Consultative Group on Poliomyelitis Vaccines.
Cockburn WC
Bull World Health Organ; 1988; 66(2):143-54. PubMed ID: 2840219
[TBL] [Abstract][Full Text] [Related]
2. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.
Bull World Health Organ; 1976; 53(4):319-31. PubMed ID: 1086727
[TBL] [Abstract][Full Text] [Related]
3. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
Furesz J; Contreras G
Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
[TBL] [Abstract][Full Text] [Related]
5. The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group.
WHO Consultative Group
Bull World Health Organ; 1982; 60(2):231-42. PubMed ID: 6980734
[TBL] [Abstract][Full Text] [Related]
6. On the role of the World Health Organization in the development of Sabin vaccines.
Magrath D; Reeve P
Biologicals; 1993 Dec; 21(4):345-8. PubMed ID: 8024749
[TBL] [Abstract][Full Text] [Related]
7. WHO recommendation on potential use of new poliomyelitis vaccines.
Ghendon Y
Dev Biol Stand; 1993; 78():133-7; discussion 138-9. PubMed ID: 8388823
[TBL] [Abstract][Full Text] [Related]
8. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
9. Risk management in a polio-free world.
Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
[TBL] [Abstract][Full Text] [Related]
10. WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.
Melnick JL; Berencsi G; Biberi-Moroeanu S; Combiescu AA; Furesz J; Kantoch M; Kostrzewski J; Magrath DI; Perkins FT; Vonka V; Cockburn WC; Dömök I; Assaad FA
Bull World Health Organ; 1972; 47(3):287-94. PubMed ID: 4346582
[TBL] [Abstract][Full Text] [Related]
11. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
12. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
13. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
15. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
Esteves K
Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113
[TBL] [Abstract][Full Text] [Related]
16. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
17. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
Kohara M; Abe S; Yoshioka I; Nomoto A
Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
[TBL] [Abstract][Full Text] [Related]
18. Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(38):996-1001. PubMed ID: 17898693
[TBL] [Abstract][Full Text] [Related]
19. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
20. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
Cáceres VM; Sutter RW
Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
